This is a Validated Antibody Database (VAD) review about human cyclin D3, based on 55 published articles (read how Labome selects the articles), using cyclin D3 antibody in all methods. It is aimed to help Labome visitors find the most suited cyclin D3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
Cell Signaling Technology
mouse monoclonal (DCS22)
  • western blot knockout validation; mouse; loading ...; fig 3c
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot knockout validation on mouse samples (fig 3c). Mol Pharmacol (2017) ncbi
Abcam
mouse monoclonal (DCS2.2)
  • western blot; human; loading ...; fig 3f
Abcam cyclin D3 antibody (Abcam, ab28283) was used in western blot on human samples (fig 3f). Commun Biol (2022) ncbi
mouse monoclonal (DCS2.2)
  • western blot; bovine; 1:1000; fig 4b
Abcam cyclin D3 antibody (Abcam, ab28283) was used in western blot on bovine samples at 1:1000 (fig 4b). Anim Reprod Sci (2020) ncbi
mouse monoclonal (DCS2.2)
  • western blot; human; loading ...; fig s1a
Abcam cyclin D3 antibody (Abcam, ab28283) was used in western blot on human samples (fig s1a). Nature (2017) ncbi
mouse monoclonal (DCS2.2)
  • western blot; human; 1:1000; fig 3
Abcam cyclin D3 antibody (Abcam, ab28283) was used in western blot on human samples at 1:1000 (fig 3). J Hematol Oncol (2015) ncbi
mouse monoclonal (DCS2.2)
  • immunohistochemistry; mouse; 1:1000
Abcam cyclin D3 antibody (Abcam, AB28283) was used in immunohistochemistry on mouse samples at 1:1000. Cell Cycle (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (D-7)
  • western blot; rat; loading ...; fig 5a
Santa Cruz Biotechnology cyclin D3 antibody (Santa Cruz Biotechnology, sc-6283) was used in western blot on rat samples (fig 5a). J Cell Biol (2021) ncbi
mouse monoclonal (DCS-22)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology cyclin D3 antibody (SCBT, DCS-22) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (D-7)
  • western blot; mouse; fig 1
In order to characterize an essential insulin effector in adipocytes called CDK4, Santa Cruz Biotechnology cyclin D3 antibody (Santa Cruz Biotechnology, sc-6283) was used in western blot on mouse samples (fig 1). J Clin Invest (2016) ncbi
mouse monoclonal (DCS-22)
  • western blot; human; fig 2
Santa Cruz Biotechnology cyclin D3 antibody (Santa Cruz, sc-56307) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (D-7)
  • western blot; human; loading ...; fig 7c
Santa Cruz Biotechnology cyclin D3 antibody (SantaCruz, sc-6283) was used in western blot on human samples (fig 7c). BMC Cancer (2014) ncbi
mouse monoclonal (1)
  • western blot; human
Santa Cruz Biotechnology cyclin D3 antibody (Santa Cruz, sc-135875) was used in western blot on human samples . Oncogene (2014) ncbi
Invitrogen
mouse monoclonal (DCS-22)
  • western blot; human; loading ...; fig 3a
In order to report the proteome of CADA-treated SUP-T1 human CD4+ T lymphocytes, Invitrogen cyclin D3 antibody (Thermo Scientific, DCS-22) was used in western blot on human samples (fig 3a). Mol Cell Proteomics (2017) ncbi
mouse monoclonal (DCS-22)
  • western blot; human
In order to screen for compounds that suppress cyclin D2 promoter transcription, Invitrogen cyclin D3 antibody (BioSource, DCS-22) was used in western blot on human samples . Blood (2009) ncbi
mouse monoclonal (DCS-22)
  • western blot; human
In order to examine the consequences of constitutive expression of anaplastic lymphoma kinase, Invitrogen cyclin D3 antibody (Neomarkers, DCS-22) was used in western blot on human samples . Blood (2006) ncbi
mouse monoclonal (DCS-22)
  • immunohistochemistry - paraffin section; human
In order to examine the role of cell-cycle regulators in the pathogenesis of acquired immune deficiency syndrome-related non-Hodgkin's lymphomas, Invitrogen cyclin D3 antibody (NeoMarkers, DCS-22) was used in immunohistochemistry - paraffin section on human samples . Am J Pathol (2002) ncbi
Cell Signaling Technology
mouse monoclonal (DCS22)
  • western blot; human; 1:200; loading ...; fig 5a
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936s) was used in western blot on human samples at 1:200 (fig 5a). Front Physiol (2022) ncbi
mouse monoclonal (DCS22)
  • western blot; human; loading ...; fig 3e
Cell Signaling Technology cyclin D3 antibody (Cell Signal, 2936) was used in western blot on human samples (fig 3e). Clin Transl Med (2021) ncbi
mouse monoclonal (DCS22)
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology cyclin D3 antibody (Cell Signaling Technology, 2936) was used in western blot on human samples at 1:1000 (fig 3b). Clin Transl Med (2021) ncbi
mouse monoclonal (DCS22)
  • western blot; mouse; loading ...; fig 4b
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, DCS22) was used in western blot on mouse samples (fig 4b). PLoS ONE (2020) ncbi
mouse monoclonal (DCS22)
  • western blot; mouse; loading ...; fig 5e
Cell Signaling Technology cyclin D3 antibody (CST, 2936) was used in western blot on mouse samples (fig 5e). Sci Rep (2020) ncbi
mouse monoclonal (DCS22)
  • western blot; human; loading ...; fig 4
Cell Signaling Technology cyclin D3 antibody (Cell Signaling Technology, 2936) was used in western blot on human samples (fig 4). Dev Reprod (2020) ncbi
mouse monoclonal (DCS22)
  • immunohistochemistry; mouse; loading ...; fig 5f
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in immunohistochemistry on mouse samples (fig 5f). J Clin Invest (2020) ncbi
mouse monoclonal (DCS22)
  • immunohistochemistry; mouse; loading ...; fig 5f
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in immunohistochemistry on mouse samples (fig 5f). Adv Sci (Weinh) (2020) ncbi
mouse monoclonal (DCS22)
  • western blot; mouse; 1:2000; loading ...; fig 4g
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot on mouse samples at 1:2000 (fig 4g). elife (2020) ncbi
mouse monoclonal (DCS22)
  • immunohistochemistry; mouse; loading ...; fig 5f
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in immunohistochemistry on mouse samples (fig 5f). Aging (Albany NY) (2020) ncbi
mouse monoclonal (DCS22)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology cyclin D3 antibody (CST, 2936) was used in western blot on human samples (fig 4c). Front Cell Dev Biol (2020) ncbi
mouse monoclonal (DCS22)
  • western blot; mouse; loading ...; fig 7d
Cell Signaling Technology cyclin D3 antibody (Cell Signaling Technology, 2936) was used in western blot on mouse samples (fig 7d). elife (2019) ncbi
mouse monoclonal (DCS22)
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology cyclin D3 antibody (CST, 2936) was used in western blot on human samples (fig 1e). Cell Rep (2019) ncbi
mouse monoclonal (DCS22)
  • western blot; mouse; loading ...; fig 4d
Cell Signaling Technology cyclin D3 antibody (Sigma, 2936) was used in western blot on mouse samples (fig 4d). Cell Rep (2019) ncbi
mouse monoclonal (DCS22)
  • western blot; human; loading ...; fig 4e
Cell Signaling Technology cyclin D3 antibody (Cell Signaling Technology, 2936) was used in western blot on human samples (fig 4e). Cancer Lett (2019) ncbi
mouse monoclonal (DCS22)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5d
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in immunohistochemistry - paraffin section on human samples (fig 5d). Cancer Cell (2018) ncbi
mouse monoclonal (DCS22)
  • other; human; loading ...; fig 4c
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (DCS22)
  • western blot; human; loading ...; fig 2g
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot on human samples (fig 2g). Oncogene (2017) ncbi
mouse monoclonal (DCS22)
  • western blot; human; fig 3d
Cell Signaling Technology cyclin D3 antibody (Cell signaling, 2936) was used in western blot on human samples (fig 3d). Science (2017) ncbi
mouse monoclonal (DCS22)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot on human samples (fig 2c). J Biol Chem (2017) ncbi
mouse monoclonal (DCS22)
  • western blot; mouse; 1:1000; loading ...; fig 4a
In order to examine the role of the E2F pathway in cardiac metabolism, Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot on mouse samples at 1:1000 (fig 4a). PLoS ONE (2017) ncbi
mouse monoclonal (DCS22)
  • immunohistochemistry - frozen section; mouse; 1:700; loading ...; fig 11h
  • western blot; mouse; 1:700; loading ...; fig 11a
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in immunohistochemistry - frozen section on mouse samples at 1:700 (fig 11h) and in western blot on mouse samples at 1:700 (fig 11a). J Neurosci (2017) ncbi
mouse monoclonal (DCS22)
  • western blot knockout validation; mouse; loading ...; fig 3c
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot knockout validation on mouse samples (fig 3c). Mol Pharmacol (2017) ncbi
mouse monoclonal (DCS22)
  • western blot; human; loading ...; fig 2
In order to report the effects of NVP-CGM097 on the p53wildtype GOT1 cells, Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot on human samples (fig 2). Neuroendocrinology (2018) ncbi
mouse monoclonal (DCS22)
  • western blot; human; 1:1000; loading ...; fig s3b
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot on human samples at 1:1000 (fig s3b). Oncogene (2017) ncbi
mouse monoclonal (DCS22)
  • western blot; mouse; loading ...; fig 1c
Cell Signaling Technology cyclin D3 antibody (Cell signaling, 2936) was used in western blot on mouse samples (fig 1c). Oncotarget (2016) ncbi
mouse monoclonal (DCS22)
  • immunohistochemistry - paraffin section; human; 1:200; fig 4
In order to investigate cyclin D1 in T-cell lymphomas, Cell Signaling Technology cyclin D3 antibody (Cell signaling, DCS22) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4). Mod Pathol (2016) ncbi
mouse monoclonal (DCS22)
  • western blot; human; 1:2000; fig 6
Cell Signaling Technology cyclin D3 antibody (Cell Signaling Tech, 2936) was used in western blot on human samples at 1:2000 (fig 6). PLoS ONE (2016) ncbi
mouse monoclonal (DCS22)
  • western blot; human; fig 8
Cell Signaling Technology cyclin D3 antibody (Cell signaling, 2936) was used in western blot on human samples (fig 8). Oncogenesis (2016) ncbi
mouse monoclonal (DCS22)
  • western blot; mouse; 1:1000; loading ...; fig s2d
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, Cell Signaling Technology cyclin D3 antibody (Cell Signaling, DCS22) was used in western blot on mouse samples at 1:1000 (fig s2d). Nat Commun (2016) ncbi
mouse monoclonal (DCS22)
  • western blot; mouse; 1:1000; fig 2c
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot on mouse samples at 1:1000 (fig 2c). FEBS Open Bio (2015) ncbi
mouse monoclonal (DCS22)
  • western blot; human; loading ...; fig 6b
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot on human samples (fig 6b). Neuroendocrinology (2016) ncbi
mouse monoclonal (DCS22)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology cyclin D3 antibody (Cell Signaling Technology, DCS22) was used in western blot on human samples at 1:1000 (fig 4a). PLoS ONE (2015) ncbi
mouse monoclonal (DCS22)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in western blot on human samples (fig 3a). Oncotarget (2015) ncbi
mouse monoclonal (DCS22)
  • immunohistochemistry; mouse; loading ...; fig 3
Cell Signaling Technology cyclin D3 antibody (Cell Signaling, 2936) was used in immunohistochemistry on mouse samples (fig 3). Cell Death Differ (2015) ncbi
mouse monoclonal (DCS22)
  • western blot; human
Cell Signaling Technology cyclin D3 antibody (Cell Signaling Technology, 2936) was used in western blot on human samples . Int J Oncol (2015) ncbi
BD Biosciences
mouse monoclonal (1/Cyclin D3)
  • flow cytometry; mouse; loading ...; fig 3b
In order to elucidate how Zfp36l1 and Zfp36l2 regulate the thymic beta-Selection checkpoint, BD Biosciences cyclin D3 antibody (BD, 1/Cyclin D3) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2016) ncbi
mouse monoclonal (1/Cyclin D3)
  • western blot; human; loading ...; fig 4h
In order to determine the function of the RNA-binding proteins ZFP36L1 and ZFP36L2 in B cells, BD Biosciences cyclin D3 antibody (BD, 1/Cyclin D3) was used in western blot on human samples (fig 4h). Science (2016) ncbi
mouse monoclonal (1/Cyclin D3)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences cyclin D3 antibody (BD, 1) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (G107-565)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences cyclin D3 antibody (BD, G107-565) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (1/Cyclin D3)
  • western blot; human; 1:1000; fig 5
BD Biosciences cyclin D3 antibody (BD Biosciences, 610279) was used in western blot on human samples at 1:1000 (fig 5). Front Microbiol (2015) ncbi
mouse monoclonal (1/Cyclin D3)
  • western blot; human; 1:700
In order to develop a neuregulin-1 overexpressing transgenic mouse model of neurofibroma-malignant peripheral nerve sheath tumor progression, BD Biosciences cyclin D3 antibody (BD Biosciences, 610279) was used in western blot on human samples at 1:700. Am J Pathol (2013) ncbi
Articles Reviewed
  1. Turco C, Esposito G, Iaiza A, Goeman F, Benedetti A, Gallo E, et al. MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer. Commun Biol. 2022;5:598 pubmed publisher
  2. Su Y, Xu J, Gao R, Liu X, Liu T, Li C, et al. The Circ-CYP24A1-miR-224-PRLR Axis Impairs Cell Proliferation and Apoptosis in Recurrent Miscarriage. Front Physiol. 2022;13:778116 pubmed publisher
  3. Zhang Y, He L, Huang L, Yao S, Lin N, Li P, et al. Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway. Clin Transl Med. 2021;11:e503 pubmed publisher
  4. Song L, Tian X, Schekman R. Extracellular vesicles from neurons promote neural induction of stem cells through cyclin D1. J Cell Biol. 2021;220: pubmed publisher
  5. Sakai H, Kawakami H, Teramura T, Onodera Y, Somers E, Furuuchi K, et al. Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer. Clin Transl Med. 2021;11:e454 pubmed publisher
  6. Chen A, Santana A, Doudican N, Roudiani N, Laursen K, Therrien J, et al. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS ONE. 2020;15:e0241551 pubmed publisher
  7. Tan Y, Sementino E, Liu Z, Cai K, Testa J. Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis. Sci Rep. 2020;10:15837 pubmed publisher
  8. Lee S, Hong K, Seong Y, Kwak S. Ectopic Overexpression of Coiled-Coil Domain Containing 110 Delays G2/M Entry in U2-OS Cells. Dev Reprod. 2020;24:101-111 pubmed publisher
  9. Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, et al. The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. J Clin Invest. 2020;: pubmed publisher
  10. Zhuo Z, Wan Y, Guan D, Ni S, Wang L, Zhang Z, et al. A Loop-Based and AGO-Incorporated Virtual Screening Model Targeting AGO-Mediated miRNA-mRNA Interactions for Drug Discovery to Rescue Bone Phenotype in Genetically Modified Mice. Adv Sci (Weinh). 2020;7:1903451 pubmed publisher
  11. Au C, Furness J, Britt K, Oshchepkova S, Ladumor H, Soo K, et al. Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531. elife. 2020;9: pubmed publisher
  12. Zhang Y, Liu C, Gao J, Shao S, Cui Y, Yin S, et al. IL-22 promotes tumor growth of breast cancer cells in mice. Aging (Albany NY). 2020;12:13354-13364 pubmed publisher
  13. Yin S, Song M, Zhao R, Liu X, Kang W, Lee J, et al. Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo. Front Cell Dev Biol. 2020;8:366 pubmed publisher
  14. Fu C, Mao W, Gao R, Deng Y, Gao L, Wu J, et al. Prostaglandin F2α-PTGFR signaling promotes proliferation of endometrial epithelial cells of cattle through cell cycle regulation. Anim Reprod Sci. 2020;213:106276 pubmed publisher
  15. Zhang S, Macias Garcia A, Ulirsch J, Velazquez J, Butty V, Levine S, et al. HRI coordinates translation necessary for protein homeostasis and mitochondrial function in erythropoiesis. elife. 2019;8: pubmed publisher
  16. Cornell L, Wander S, Visal T, Wagle N, Shapiro G. MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance. Cell Rep. 2019;26:2667-2680.e7 pubmed publisher
  17. Lin K, Qiang W, Zhu M, Ding Y, Shi Q, Chen X, et al. Mammalian Pum1 and Pum2 Control Body Size via Translational Regulation of the Cell Cycle Inhibitor Cdkn1b. Cell Rep. 2019;26:2434-2450.e6 pubmed publisher
  18. Song X, Chen H, Zhang C, Yu Y, Chen Z, Liang H, et al. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019;442:310-319 pubmed publisher
  19. Stewart E, McEvoy J, Wang H, Chen X, Honnell V, Ocarz M, et al. Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses. Cancer Cell. 2018;34:411-426.e19 pubmed publisher
  20. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  21. Zhou Y, Huang T, Zhang J, Wong C, Zhang B, Dong Y, et al. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene. 2017;36:6518-6530 pubmed publisher
  22. Wang H, Nicolay B, Chick J, Gao X, Geng Y, Ren H, et al. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature. 2017;546:426-430 pubmed publisher
  23. Chavali P, Stojic L, Meredith L, Joseph N, Nahorski M, Sanford T, et al. Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication. Science. 2017;357:83-88 pubmed publisher
  24. Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292:7866-7887 pubmed publisher
  25. Major J, Dewan A, Salih M, Leddy J, Tuana B. E2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated Cardiomyopathy. PLoS ONE. 2017;12:e0170066 pubmed publisher
  26. Hussain R, Macklin W. Integrin-Linked Kinase (ILK) Deletion Disrupts Oligodendrocyte Development by Altering Cell Cycle. J Neurosci. 2017;37:397-412 pubmed publisher
  27. Choiniere J, Wu J, Wang L. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. Mol Pharmacol. 2017;91:189-196 pubmed publisher
  28. Van Puyenbroeck V, Claeys E, Schols D, Bell T, Vermeire K. A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA). Mol Cell Proteomics. 2017;16:157-167 pubmed publisher
  29. Reuther C, Heinzle V, Nölting S, Herterich S, Hahner S, Halilovic E, et al. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. Neuroendocrinology. 2018;106:1-19 pubmed publisher
  30. Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene. 2017;36:1573-1584 pubmed publisher
  31. Vogel K, Bell L, Galloway A, Ahlfors H, Turner M. The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic ?-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. J Immunol. 2016;197:2673-2685 pubmed publisher
  32. Ramazzotti G, Billi A, Manzoli L, Mazzetti C, Ruggeri A, Erneux C, et al. IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation. Oncotarget. 2016;7:84118-84127 pubmed publisher
  33. Song J, Song L, Herrera A, Venkataraman G, Murata Collins J, Bedell V, et al. Cyclin D1 expression in peripheral T-cell lymphomas. Mod Pathol. 2016;29:1306-1312 pubmed publisher
  34. O Santos A, Parrini M, Camonis J. RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases. PLoS ONE. 2016;11:e0154840 pubmed publisher
  35. Galloway A, Saveliev A, Łukasiak S, Hodson D, Bolland D, Balmanno K, et al. RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence. Science. 2016;352:453-9 pubmed publisher
  36. Chaudhary S, Madhukrishna B, Adhya A, Keshari S, Mishra S. Overexpression of caspase 7 is ER? dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip). Oncogenesis. 2016;5:e219 pubmed publisher
  37. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  38. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  39. Lagarrigue S, Lopez Mejia I, Denechaud P, Escoté X, Castillo Armengol J, Jimenez V, et al. CDK4 is an essential insulin effector in adipocytes. J Clin Invest. 2016;126:335-48 pubmed publisher
  40. Suwei D, Liang Z, Zhimin L, Ruilei L, Yingying Z, Zhen L, et al. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. J Hematol Oncol. 2015;8:120 pubmed publisher
  41. Anderson K, Russell A, Foletta V. NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicity. FEBS Open Bio. 2015;5:668-81 pubmed publisher
  42. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher
  43. Marzagalli M, Casati L, Moretti R, Montagnani Marelli M, Limonta P. Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines. PLoS ONE. 2015;10:e0134396 pubmed publisher
  44. Yang S, Lin H, Chang V, Chen C, Liu Y, Wang J, et al. Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo. Oncotarget. 2015;6:23857-73 pubmed
  45. Suzuki M, Takeda T, Nakagawa H, Iwata S, Watanabe T, Siddiquey M, et al. The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas. Front Microbiol. 2015;6:280 pubmed publisher
  46. Puzio Kuter A, Laddha S, Castillo Martin M, Sun Y, Cordon Cardo C, Chan C, et al. Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma. Cell Death Differ. 2015;22:1785-91 pubmed publisher
  47. Wang Y, Han A, Chen E, Singh R, Chichester C, Moore R, et al. The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells. Int J Oncol. 2015;46:1924-34 pubmed publisher
  48. Dong X, Lin Q, Aihara A, Li Y, Huang C, Chung W, et al. Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype. Oncotarget. 2015;6:1231-48 pubmed
  49. Zakaria M, Khan I, Mani P, Chattopadhyay P, Sarkar D, Sinha S. Combination of hepatocyte specific delivery and transformation dependent expression of shRNA inducing transcriptional gene silencing of c-Myc promoter in hepatocellular carcinoma cells. BMC Cancer. 2014;14:582 pubmed publisher
  50. Garcia T, Hofmann M. NOTCH signaling in Sertoli cells regulates gonocyte fate. Cell Cycle. 2013;12:2538-45 pubmed publisher
  51. Shan L, Li X, Liu L, Ding X, Wang Q, Zheng Y, et al. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation. Oncogene. 2014;33:3205-16 pubmed publisher
  52. Kazmi S, Byer S, Eckert J, Turk A, Huijbregts R, Brossier N, et al. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis. Am J Pathol. 2013;182:646-67 pubmed publisher
  53. Tiedemann R, Schmidt J, Keats J, Shi C, Zhu Y, Palmer S, et al. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo. Blood. 2009;113:4027-37 pubmed publisher
  54. Piva R, Chiarle R, Manazza A, Taulli R, Simmons W, Ambrogio C, et al. Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood. 2006;107:689-97 pubmed
  55. Gloghini A, Gaidano G, Larocca L, Pierconti F, Cingolani A, Dal Maso L, et al. Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1. Am J Pathol. 2002;161:163-71 pubmed